Mostra 1 - 5 risultati di 5 ricerca 'Seyed Reza Mousavi (13223324)', tempo di risposta: 0,01s Raffina i risultati
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. di Seyed Reza Mousavi (13223324)

    Pubblicazione 2025
    Aggiungi alla lista
    Salvato in:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. di Seyed Reza Mousavi (13223324)

    Pubblicazione 2025
    Aggiungi alla lista
    Salvato in:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. di Seyed Reza Mousavi (13223324)

    Pubblicazione 2025
    Aggiungi alla lista
    Salvato in:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. di Seyed Reza Mousavi (13223324)

    Pubblicazione 2025
    Aggiungi alla lista
    Salvato in:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. di Seyed Reza Mousavi (13223324)

    Pubblicazione 2025
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: